Briakinumab, CAS [[339308-60-0]]

Produktübersicht

• Artikelname: Briakinumab, CAS [[339308-60-0]]
• Artikelnummer: AMO-M25215
• Hersteller Artikelnummer: M25215
• Alternativnummer: AMO-M25215-100UG,AMO-M25215-1MG
• Hersteller: Abmole Bioscience
• Kategorie: Biochemikalien
• Alternative Synonym: ABT-874

Produktbeschreibung

Briakinumab (ABT-874) is a fully human anti-IL-12/23p40 monoclonal antibody. Briakinumab targets and neutralizes IL-12 and IL-23. Briakinumab can be used for the research of rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.

Produkteigenschaften

• CAS Nummer: [339308-60-0]
• Target-Kategorie: IL Receptor/Related